Fibroblast Growth Factors and Their Receptors in Breast and Prostate Cancer

  • R. C. Coombes
  • S. Marsh
  • J. Gomm
  • C. Johnston
Part of the Contemporary Endocrinology book series (COE)


The fibroblast growth factor (FGF) family has emerged as perhaps the largest group of polypeptide growth factors to be involved in cellular growth and differentiation. It presently comprises more than 20 published members that share a varying degree of homology, and, with the exception of FGF7 and FGF10, which specifically act on epithelial cells (ECs), have a similar broad mitogenic spectrum, i.e., they promote the proliferation of a variety of cells, including those of mesodermal origin, and are angiogenic. With the exception of FGF8, their genes have similar organization and, in some cases, map to comparable regions on human and mouse chromosomes. Their pattern of expression is very different, ranging from restricted expression in some stages of development, e.g., FGF3, FGF4, and FGF5, to rather ubiquitous expression in a variety of tissues and organs, in the cases of FGF1 and FGF2. They all appear to bind heparin and heparan sulphate proteoglycans (HSPG) in the extracellular matrix, which originally led to their alternative grouping, as the heparin-binding growth factors (1).


Breast Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor Basic Fibroblast Growth Factor Mouse Mammary Tumor Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burgess WH, Macaig T. The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989; 58: 575–606.PubMedGoogle Scholar
  2. 2.
    Delli Bovi P, Curatoia AM, Kern FG, Greco A, Ittmann M, Basilico C. An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 1987; 50: 729–737.Google Scholar
  3. 3.
    Zhan X, Bates B, Hu X, Goldfarb M. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factor. Mol Cell Biol 1988; 8: 3487–3495.PubMedGoogle Scholar
  4. 4.
    Partanen J, Vainikka S, Akitako K. Structural and functional specificity of FGF receptors. Phil Trans R Soc Lond 1993; 340: 297–303.Google Scholar
  5. 5.
    Maries L, Adelaide J, Raybaud F, Mattei M-G, Coulier F, Planche J, de Lapeyriere O, Birnbaum D. Characterisation of the HST-related FGF6 gene, a new member of the fibroblast growth factor gene family. Oncogene 1989; 4: 335–340.Google Scholar
  6. 6.
    Finch PW, Rubin JS, Miki R, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracine effector of epithelial cell growth. Science 1989; 245: 752–755.PubMedGoogle Scholar
  7. 7.
    Hecht D, Zimmerman N, Bedford N, Avivi A, Yayon A. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4. Growth Factors 1995; 12: 223–233.PubMedGoogle Scholar
  8. 8.
    Yamasaki M, Miyake A, Tagashire S, Itoh N. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J Biol Chem 1996;271:15, 918–15, 921.Google Scholar
  9. 9.
    Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, aprotein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992; 151: 81–93.PubMedGoogle Scholar
  10. 10.
    Joaunneau J, Gavrilovic J, Caruelle D, Jaye M, Moens G, Caruells JP, Thiery JP. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc Natl Acad Sci USA 1991; 88: 2893–2897.Google Scholar
  11. 11.
    Chao HH, Yang VC, Chen JK. Acidic FGF and EGF are involved in the autocrine growth stimulation of a human nasopharyngeal carcinoma cell line and sub-line cells. Int J Cancer 1993; 54: 807–812.PubMedGoogle Scholar
  12. 12.
    Klagsbrun M, Baird A. Dual receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229–231.PubMedGoogle Scholar
  13. 13.
    Ruta M, Howk R, Ricca G, Drohan W, Zabelshansky M, Laureys G, et al. Novel protein tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene 1988; 3: 9–15.Google Scholar
  14. 14.
    Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 1989; 245: 57–60.PubMedGoogle Scholar
  15. 15.
    Johnson DE, Lu J, Chen H, Werner S, Williams LT. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanism for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 1991; 11: 4627–4634.PubMedGoogle Scholar
  16. 16.
    Hou JZ, Kan MK, McKeehan K, McBride G, McKeehan WL. Fibroblast growth factor receptors from liver vary in three structural domains. Science 1991; 251: 665–668.PubMedGoogle Scholar
  17. 17.
    Jaye M, Schlessinger J, Dionne CA. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1992; 1135: 185–199.PubMedGoogle Scholar
  18. 18.
    Vainikka S, Partanen S, Bellosta P, Coulier C, Basilico C, Jaye M, Alitalo K. Fibroblast growth factor receptor-4 shows novel features in genome structure, ligand binding, and signal transduction. EMBO J 1992; 11: 4273–4280.PubMedGoogle Scholar
  19. 19.
    Zimmer Y, Givol D, Yayon A. Multiple structural elements determine ligand binding of fibroblast growth factor receptors. J Biol Chem 1993; 268: 7899–7903.PubMedGoogle Scholar
  20. 20.
    Wang F, Kan M, Xu J, Yan G, McKeehan WL. Ligand-specific structural domains in the fibroblast growth factor receptor. J Biol Chem 1995;270;10, 222–10, 230.Google Scholar
  21. 21.
    Wang F, Kan M, McKeehan K, Feng S, McKeehan WL. A homeointeraction sequence in the ectodomain of the fibroblast growth factor receptor. J Biol Chem 1997;272:23, 887–23, 895.Google Scholar
  22. 22.
    Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213–223.PubMedGoogle Scholar
  23. 23.
    Fantl WJ, Johnson DE, William LT. Signalling by receptor tyrosine kinases. Ann Rev Biochem 1993; 62: 453–481.PubMedGoogle Scholar
  24. 24.
    Hou JZ, Kan MK, McKeehan K, McBride G, McKeehan WL. Fibroblast growth factor receptors from liver vary in three structural domains. Science 1991; 251: 665–668.PubMedGoogle Scholar
  25. 25.
    Coleman-Krnaick S, Rosen JM. Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol 1994; 8: 218–229.Google Scholar
  26. 26.
    Bansal GS, Yiangou C, Coope RC, Gomm JJ, Luqmani YA, Coombes RC, Johnston CL. Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast. Br J Cancer 1995; 72: 1420–1426.PubMedGoogle Scholar
  27. 27.
    Renaud F, El Yazidi I, Boilly-Marer Y, Cortois Y, Laurent M. Expression and regulation by serum of multiple FGF1 mRNA in normal transformed, and malignant human mammary epithelial cells. Biochem Biophys Res Commun1996; 219: 679–685.Google Scholar
  28. 28.
    Penault-Llorca F, Bertucci F, Adelaide J, Parc RC, Coulier F, Jacquemier J, Birnbaum D, Delapeyrier O. Expression of FGF and FGF receptors in human breast cancer. Int J Cancer 1995; 61: 170–176.PubMedGoogle Scholar
  29. 29.
    Lugmani YA, Graham M, Coombes RC. Expression of basic fibroblast growth factor, FGFR 1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 1992; 66: 273–280.Google Scholar
  30. 30.
    Anandappa SY, Winstanley JHR, Leinster S, Green B, Rudland PS, Barraclough R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 1994; 69: 772–776.PubMedGoogle Scholar
  31. 31.
    Coope RC, Browne PJ, Yiangou C, Bansal GS, Walters J, Groome N, et al. The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue. Br J Cancer 1997; 75: 1621–1630.PubMedGoogle Scholar
  32. 32.
    Smith J, Yelland A, Baillie R, Coombes RC. Acidic and basic fibroblast growth factors in human breast tissue. Eur J Cancer 1994; 30A: 496–503.Google Scholar
  33. 33.
    Johnston CL, Cox HC, Gomm JJ, Coombes RC. Fibroblast growth factor receptors localise in different cellular compartments. J Biol Chem 1995; 270: 1–8.Google Scholar
  34. 34.
    McLeskey SW, Ding IYF, Lippman ME, Kern HG. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res 1994; 54: 523–530.PubMedGoogle Scholar
  35. 35.
    Imagawa W, Cunha GR, Young P, Nandi S. Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun 1994; 204: 1165–1169.PubMedGoogle Scholar
  36. 36.
    Gomm JJ, Browne PJ, Coope RC, Bansal GS, Yiangou C, Johnston CL, Mason R, Coombes RC. A paracrine role for myoepithelial cell-derived FGF2 in the normal human breast. Exp Cell Res 1997; 234: 165–173.PubMedGoogle Scholar
  37. 37.
    Souttou B, Gamby C, Crepin M, Hamelin R. Tumoral progression of human breast epithelial cells secreting FGF2 and FGF4. Int J Cancer 1996; 68: 675–681.PubMedGoogle Scholar
  38. 38.
    Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding I, et al. MCF-7 breast carcinoma cells overexpressing FGF-1 from vascularised, metastatic tumors in ovariectomised or tamoxifen-treated nude mice. Oncogene 1997; 15: 2093–2108.PubMedGoogle Scholar
  39. 39.
    McLeskey SW, Zhang L, El-Ashey D, Trock BJ, Lopez CA, Kharbanda S, et al. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. Clin Cancer Res 1998; 4: 697–711.PubMedGoogle Scholar
  40. 40.
    Jouanneau J, Moens G, Montesano R, Thiery J-P. FGF-1 but not FGF-4 secreted by carcinoma cells Promotes in vitro and in vivo angiogenesis and rapid tumour proliferation. Growth Factors 1995; 12: 37–47.PubMedGoogle Scholar
  41. 41.
    Li S, Shipey GD. Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture. Cell Growth Differ 1991; 2: 195–202.PubMedGoogle Scholar
  42. 42.
    Gomm JJ, Browne PJ, Coope RC, Bansal GS, Yiangou C, Johnston CL, Mason R, Coombes RC. A paracrine role for myoepithelial cell-derived FGF2 in the normal human breast. Exp Cell Res 1997; 234: 165–173.PubMedGoogle Scholar
  43. 43.
    Plopper GE, McNamee PH, Dike LE, Bojanowski K, Ignber DE. Convergence of intergrin and growth factor receptor signalling pathways within the focal adhesion complex. Mol Biol Cell 1995; 6: 1349–1365.PubMedGoogle Scholar
  44. 44.
    Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombes RC. Localisation of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland. Cancer Res 1991; 51: 4685–4692.PubMedGoogle Scholar
  45. 45.
    Yiangou C, Johnston CL, Gomm JJ, Coope RC, Luqmani YA, Shousha S, Coombes RC. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer 1997; 75: 38–33.Google Scholar
  46. 46.
    Wang H, Rubin M, Fenig E, DeBlasio A, Mendelson J, Yahalom J. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory GI events. Cancer Res 1977; 57: 1750–1757.Google Scholar
  47. 47.
    Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17(3-estradiol. Cancer Res 1988; 38: 4083–4092.Google Scholar
  48. 48.
    Stewart AJ, Westly BR, May FE. Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 1992; 66: 640–648.PubMedGoogle Scholar
  49. 49.
    Fenig E, Wider R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J. Basic fibroblast growth factor confers growth inhibition and ERK activation in human breast cancer cells. Clin Cancer Res 1997; 3: 135–142.PubMedGoogle Scholar
  50. 50.
    Weider R, Wang H, Shirke S, Wang O, Menzel T, Feirt N, Jakubowksi AA, Gabrilove JL. Low level expression of basic FGF upregulates Bc1–2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 1997; 15: 41–60.Google Scholar
  51. 51.
    Wang Y, Beck D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 1997; 3: 887–893.PubMedGoogle Scholar
  52. 52.
    Miyake H, Hara I, Yoshimura K, Eto H, Arakaw S, Wada S, Chihara K, Kamidono S. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 1996; 56: 2440–2445.PubMedGoogle Scholar
  53. 53.
    Rusnati M, Dell’Era P, Urbinati C, Tanghetti E, Massardi ML, Nagamine Y, Monti E, Presta M. Distinct basic fibroblast growth factor (FGF-2)?FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol Biol Cell 1996; 7: 369–381.PubMedGoogle Scholar
  54. 54.
    Rubin JS, Osada H, Finch PW, Taylor GW, Rudikoff S, Aaaronson SA. Purification and characterisation of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989; 86: 802–806.PubMedGoogle Scholar
  55. 55.
    Emoto H, Tagashira S, Mattei MG, Yamasaki M, Hashimoto G, Katsumata T, et al. Structure and expression of human fibroblast factor 10. J Biol Chem 1997;272:23, 191–23, 194.Google Scholar
  56. 56.
    Miki T, Fleming TP, Bottaro DP, Rubib JS, Ron D, Aaronson SA. Expression cDNA cloning of the KGF receptor by reaction of a transforming autocrine loop. Science 1991; 251: 27–75.Google Scholar
  57. 57.
    Yayon A, Zimmer Y, Guo-Hong S. Avivi A, Yosef Y, Givol D. A confined variable region confer ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J 1992; 11: 1885–1890PubMedGoogle Scholar
  58. 58.
    Pekonen F, Nyman T, Rutanen EM, Differential expression ofkeratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 1993; 95: 43–49.PubMedGoogle Scholar
  59. 59.
    Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma. Mol Cell Biol 1994; 5: 851–862.Google Scholar
  60. 60.
    Luqmani YA, Bansal GS, Mortimer C, Buluwela L, Coombes RC. Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast. Eur J Cancer 1996; 32A: 518–524.Google Scholar
  61. 61.
    Ulich TR, Yi ES, Cardiff R, Yin S, Bikhazi N, Biltz R, Morris CF, Pierce GF. Keratinocyte growth factor is a growth factor for mammary epithelium. In vivo. Am J Pathol 1994; 144: 862–868.PubMedGoogle Scholar
  62. 62.
    Kitsberg DI, Leder P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 1996; 13: 2507–2515.PubMedGoogle Scholar
  63. 63.
    Ishii H, Yoshida T, Oh H, Yoshida S, Terada M. A Truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol Cell Biol 1995; 15: 3664–3671.PubMedGoogle Scholar
  64. 64.
    Lorenzi MV, Castagnino P, Chen Q, Chedid M, Miki T. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations. Oncogene 1997; 15: 817–826.PubMedGoogle Scholar
  65. 65.
    Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary-carcinoma cells. Proc Natl Acad Sci USA 1992; 89: 8928–8932.PubMedGoogle Scholar
  66. 66.
    Crossley PH, Martin GR. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development (Camb)1995; 121: 439–451.Google Scholar
  67. 67.
    MacArthur CA, Lawshe A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT, Ornitz DM. FGF8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development (Camb) 1995; 121: 3603–3613.Google Scholar
  68. 68.
    Crossley PH, Martinez S, Martin GR. Midbrain development induced by FGF8 in the chick embryo. Nature (Lond) 1996; 380: 66–68.Google Scholar
  69. 69.
    Crossley PH, Minowada G, MacArthur CA, Martin GR. Roles for FGF8 in the induction, initiation and maintenance of chick limb development. Cell 1996; 84: 127–136.PubMedGoogle Scholar
  70. 70.
    MacArthur CA, Shankar DB, Shackleford GM. FGF-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumourigenesis. J Virol 1995; 69: 2501–2507.PubMedGoogle Scholar
  71. 71.
    Lorenzi MV, Long JE, Miki T, Aaronson SA. Expression cloning, developmental expression and chromosomal localization of fibroblast growth factor-8. Oncogene 1995; 10: 2051–2055.PubMedGoogle Scholar
  72. 72.
    Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T, Sato B. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene 1994; 9: 455–462.PubMedGoogle Scholar
  73. 73.
    Gemel J, Gorry M, Enruch GD. Structure and sequence of human FGF8. Genomics 1996; 35: 253–257.PubMedGoogle Scholar
  74. 74.
    Ghosh AK, Shankar DB, Shackleford GM, Wu K, T’Ang A, Miller GJ, Zheng J, Roy-Burman P. Molecular cloning and characterisation of human FGF8 alternative messenger RNA forms. Cell Growth Differ 1996; 7: 1425–1434.PubMedGoogle Scholar
  75. 75.
    MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 1995; 6: 817–825.PubMedGoogle Scholar
  76. 76.
    Kapoun AM, Shackleford GM. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wntl transgenic mice. Oncogene 1997; 14: 2985–2989.PubMedGoogle Scholar
  77. 77.
    Daphna-Iken D, Shankar DB, Lawshe A, Ornitz DM, Shackleford GM, MacArthur CA. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 1998; 17: 2711–2717.PubMedGoogle Scholar
  78. 78.
    Marsh SK, Bansal GS, Zammit C, Barnard R, Coope R, Roberts-Clarke D, et al. Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 1999; 18: 1052–1060.Google Scholar
  79. 79.
    Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H. Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett 1995; 363: 226–230.PubMedGoogle Scholar
  80. 80.
    Bansal GS, Cox HC, Marsh S, Gomm JJ, Yiangou C, Luqmani Y, Coombes RC, Johnston CL. Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer 1997; 75: 1567–1574.PubMedGoogle Scholar
  81. 81.
    Kornbluth S, Paulson KS, Hanafusa H. Novel tyrosine kinase identified by phosphotyrosine antibody screening. Mol Cell Biol 1988; 8: 5541.PubMedGoogle Scholar
  82. 82.
    Reid HH, Wilks AF, Bernard O. Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain. Proc Natl Acad Sci USA 1990; 87: 1596.PubMedGoogle Scholar
  83. 83.
    Ruta M, Burgess W, Givol D, Epstein J, Neiger N, Kaploy J, et al. Receptor for acidid fibroblast growth factor is related to tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci USA 1989; 86: 8722–8726.PubMedGoogle Scholar
  84. 84.
    Mattei MG. Moreau A, Gesnel MC, Houssaint E, Breatnach R. Assignment by in situ hydridisation of a fibroblast growth factor receptor gene to human chomosome band 10g26. Hum Genet 1991; 87: 84–86.PubMedGoogle Scholar
  85. 85.
    Dionne C, Modi W, Crumley G, O’Brien S, Schlessinger J, Jaye M. BEK, a receptor for multiple members of the fibroblast growth factor (FGF) family, maps to human chromosome 10g25.3-q26. Cytogenet Cell Genet 1992; 60: 34–36.PubMedGoogle Scholar
  86. 86.
    Theillet C, Adelaide J, Louason G, Bonnet-Doriun F, Jacquemier J, Adnane J, et al. FGFR1 and Plat genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 1993; 7: 219–226.PubMedGoogle Scholar
  87. 87.
    Jacquemier J, Adelaide J, Parc P, Penault-Llorca F, Planche J, DeLapeyiere O, Birnbaum D. Expression of the FGFR1 gene in human breast carcinoma cells. Int J Cancer 1994; 59: 373–378.PubMedGoogle Scholar
  88. 88.
    Luqmani Y, Mortimer C, Yiangou C, Johnston CL, Bansal GS, Sinnett D, Law M, Coombes RC. Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast. Int J Cancer 1995; 64: 274–279.PubMedGoogle Scholar
  89. 89.
    Peyrat JP, Bonneterre J, Hondermarck H, Hecquet B, Adenis A, Louchez MM, et al. Basic fibroblast growth factor (bFGF): mitogenic activity and binding sites in human breast cancer. J Steroid Biochem Mol Biol 1992; 43: 87–94.PubMedGoogle Scholar
  90. 90.
    Hughes SE, Hall PA. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993; 69: 173–182.PubMedGoogle Scholar
  91. 91.
    Morikawa Y, Ishihara Y, Tohya K, Kakudo K, Kurokawa M, Matsuura N. Expression of the fibroblast growth factor receptor-1 in human normal tissues and tumours determined by a new monoclonal antibody. Arch Pathol Lab Med 1996; 120: 490–496.PubMedGoogle Scholar
  92. 92.
    Prudovsky IA, Savion N, LaVallee TM, Maciag T. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 Correlates with the perinuclear association of the FGF receptor-1a isoforms but not the FGF receptor-1D isoforms. J Biol Chem 1996;271:14, 198–14, 205.Google Scholar
  93. 93.
    Migdal M, Soker S, Yarden Y, Neufeld G. Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties. J Cell Physiol 1995; 162: 266–276.PubMedGoogle Scholar
  94. 94.
    Langren E, Klint P, Yokote K, Claesson-Welsh L. Fibroblast growth factor receptor 1 mediates chemotaxis independently of direct SH-2-domain protein binding. Oncogene 1998; 17: 283–291.Google Scholar
  95. 95.
    Johnston MR, Valentine C, Basilico C, Mansukhani A. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene 1998; 16: 2647–2656.Google Scholar
  96. 96.
    Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, et al. Activation of Statl by mutant fibroblast growth-factor receptor in thanatopheric dysplasia in type II dwarfism. Nature 1997; 386: 288–292.PubMedGoogle Scholar
  97. 97.
    Yan G, Fukabori Y, McBride G, Nikolaropolous SM, McKeehan WL. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993; 13: 4513–4522.PubMedGoogle Scholar
  98. 98.
    Carstens RP, Eaton JV, Krigman HR, Walther PJ, Garcia-Blanco MA. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene 1997; 15: 3059–3065.PubMedGoogle Scholar
  99. 99.
    Storey MT, Hopp KA, Molter M, Meier DA. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 1994; 10: 269–280.Google Scholar
  100. 100.
    Ropiquet F, Berthon P, Villette J-M, Le Brun G. Maitland NJ, Cussenot O, Fiet J. Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype. Int J Cancer 1997; 72: 532–547.Google Scholar
  101. 101.
    Nakamota T, Chang CS, Li AK, Chodak GW. Basic fibroblast growth factor in human prostate-cancer cells. Cancer Res 1992; 52: 571–577.Google Scholar
  102. 102.
    Ittman M, Mansukhani A. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 1997; 157: 351–356.PubMedGoogle Scholar
  103. 103.
    Sherwood E, Fong C, Lee C, Kozlowski J. Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 1992; 130: 2955.Google Scholar
  104. 104.
    Story MT. Regulation of prostate growth by fibroblast growth factors. World J Urol 1995; 13: 297–305.PubMedGoogle Scholar
  105. 105.
    Schmitt JF, Hearn MTW, Risbridger GP. Expression of fibroblast growth factor 8 in adult rat tissues and human prostate carcinoma cells. J Steroid Biochem Mol Biol 1996; 57: 173–178.PubMedGoogle Scholar
  106. 106.
    Leung HY, Dickson C, Robson CN, Neal DE. Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 1996; 12: 1833–1835.PubMedGoogle Scholar
  107. 107.
    Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T, et al. High frequency fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF8. Cancer Res 1998; 58: 2053–2056.PubMedGoogle Scholar
  108. 108.
    Cunha GR, Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994; 74: 1030–1044.PubMedGoogle Scholar
  109. 109.
    Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, et al. Keratinocyte growth factor. Cell Biol Int 1995; 19: 339–411.Google Scholar
  110. 110.
    De Bellis A, Crescioli C, Grappone C, Milani S, Ghiandi P, Forti G, Serio M. Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue. J Clin Endocrinol Metab 1998; 83: 2186–2191.PubMedGoogle Scholar
  111. 111.
    Nemeth JA, Zelner DJ, Lang S, Lee C. Keratinocyte growth factor in the rat ventral prostate androgen-independent expression. J Endocrinol 1998; 156: 115–125.PubMedGoogle Scholar
  112. 112.
    Fasciana C, Van-Der-Made AC, Faber PW, Trapman J. Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter. Biochem Biophys Res Commun 1996; 220: 858–863.PubMedGoogle Scholar
  113. 113.
    Chedid M. Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994;269:10, 753–10, 757.Google Scholar
  114. 114.
    Feng S, Wang F, Matsubara A, Kan M, McKeehan WL. Fibroblast growth factor receptor 2 limits and receptor l accelerated tumorigenicity of prostate epithelial cells. Cancer Res 1997; 57: 5369–5378.PubMedGoogle Scholar
  115. 115.
    Matsubara A, Kan M, Feng S, McKeehan WL. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 1998; 58: 1509–1514.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • R. C. Coombes
  • S. Marsh
  • J. Gomm
  • C. Johnston

There are no affiliations available

Personalised recommendations